Showing results (281-290 of 297) with videos related to
Sort By:
Pageof 30
Bioorganic & Medicinal Chemistry Letters|November 29, 2011
Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the seriesArthur Oubrie, Allard Kaptein, Edwin de Zwart, et al.American Journal of Respiratory and Critical Care Medicine|October 4, 2018
Elastase Exocytosis by Airway Neutrophils Is Associated with Early Lung Damage in Children with Cystic FibrosisCamilla Margaroli, Luke W Garratt, Hamed Horati, et al.Nature Communications|April 21, 2016
Identification of pyrazolopyridazinones as PDEδ inhibitorsBjörn Papke, Sandip Murarka, Holger A Vogel, et al.Biorxiv : the Preprint Server for Biology|July 3, 2026
Identifying Novel Estrogenic Mitochondrial Targets in Hypothalamic Proopiomelanocortin Neurons by ChemoproteomicsJian Qiu, Martha A Bosch, Mya Wolfe, et al.Science Signaling|May 11, 2017
Tetraspanin microdomains control localized protein kinase C signaling in B cellsMalou Zuidscherwoude, Vera-Marie E Dunlock, Geert van den Bogaart, et al.Bioorganic & Medicinal Chemistry Letters|May 14, 2011
Structure-based lead identification of ATP-competitive MK2 inhibitorsTjeerd Barf, Allard Kaptein, Sander de Wilde, et al.Bioorganic & Medicinal Chemistry Letters|May 14, 2011
Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitorsAllard Kaptein, Arthur Oubrie, Edwin de Zwart, et al.Nature|February 21, 2014
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cellsMagdalena Paolino, Axel Choidas, Stephanie Wallner, et al.Cell Metabolism|July 15, 2025
Localized GLP1 receptor pre-internalization directs pancreatic alpha cell to beta cell communicationJason C L Tong, Charlotte Frazer-Morris, Ali H Shilleh, et al.Chemmedchem|September 30, 2017
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of CancerUlrich Lücking, Arne Scholz, Philip Lienau, et al.Pageof 30